1887
Preview this article:
Zoom in
Zoomout

Ciprofloxacin resistance in serotype Typhi/Paratyphi and antimicrobial agent quality and bioavailability, Page 1 of 1

| /docserver/preview/fulltext/jmm/55/7/965-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46413-0
2006-07-01
2020-11-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/7/965.html?itemId=/content/journal/jmm/10.1099/jmm.0.46413-0&mimeType=html&fmt=ahah

References

  1. Ofoeule S. I., Udeogaranya P. O., Okonata J. M. 2001; Prediction of in vivo bioavailability of six brands of ciprofloxacin film coated tablets using the concept of dissolution efficiency (DE). Boll Chim Farm 140:187–191
    [Google Scholar]
  2. Renuka K., Sood S., Das B. K., Kapil A. 2005; High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 54:999–1000 [CrossRef]
    [Google Scholar]
  3. Taylor R. B., Shakoor O., Behrens R. H., Everard M., Low A. S., Wangboonskul J., Reid R. G., Kolawole J. A. 2001; Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 357:1932–1936
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46413-0
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error